UBS Reiterates Buy Rating on BioNTech (BNTX) Following Lung Cancer Updates
Go back to UBS Reiterates Buy Rating on BioNTech (BNTX) Following Lung Cancer Updates| (NASDAQ: BNTX) | Delayed: 101.52 +3.52 (3.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.00 | 52 Week High | $ | |||
| Open | $98.00 | 52 Week Low | $ | |||
| Day High | $102.23 | P/E | N/A | |||
| Day Low | $97.46 | EPS | $ | |||
| Volume | 776,725 | |||||
